Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07153406 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Comparison of Esketamine Nasal Spray vs.Aripiprazole in Treat.Resistant Major Depressive Disorder in Elderly Patients

Name: Comparison of Esketamine Nasal Spray vs.Aripiprazole in Treat.Resistant Major Depressive Disorder in Elderly Patients — clinical trial record (NCT07153406)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: CESAR

StatusNot Yet Recruiting

PhasePhase 3

SponsorFundación Pública Andaluza para la gestión de la Investigación en Sevilla

Started2025-09-15

View on ClinicalTrials.gov ↗

Record status

This record was last updated September 4, 2025 (before its estimated September 15, 2026 completion). Its status may not reflect the trial's current state.

Fundación Pública Andaluza para la gestión de la Investigación en Sevilla

27 trials monitored

See all monitored trials

Depression

2,976 trials monitored

See 162 trials at risk

Phase III, open label, randomised, multicentre, blind for evaluators clinical trial to evaluate the efficacy of esketamine nasal spray at flexible dosis compared to aripiprazole in elderly participants (\>60 years) who suffer from treatment-resistant major depressive

Trial Details

NCT Number	NCT07153406
Lead Sponsor	Fundación Pública Andaluza para la gestión de la Investigación en Sevilla
Conditions	Depressive Disorder
Enrollment	220 participants
Start Date	2025-09-15
Primary Completion	2026-09-15 (estimated)
Study Completion	2029-01-15 (estimated)
Updated on ClinicalTrials.gov	2025-09-04